A N Vallejo

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi Modulation of CD28 expression: distinct regulatory pathways during activation and replicative senescence
    A N Vallejo
    Division of Rheumatology, Department of Medicine, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    J Immunol 162:6572-9. 1999
  2. ncbi Biology of T lymphocytes
    Abbe N Vallejo
    Departments of Medicine and Immunology, Guggenheim 401, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Rheum Dis Clin North Am 30:135-57. 2004
  3. ncbi Molecular basis for the loss of CD28 expression in senescent T cells
    Abbe N Vallejo
    Department of Medicine and Immunology, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Biol Chem 277:46940-9. 2002
  4. ncbi T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection
    Abbe N Vallejo
    Division of Rheumatology, Department of Medicine, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    Trends Mol Med 10:119-24. 2004
  5. ncbi Clonality and longevity of CD4+CD28null T cells are associated with defects in apoptotic pathways
    A N Vallejo
    Departments of Medicine and Immunology, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    J Immunol 165:6301-7. 2000
  6. ncbi Functional disruption of the CD28 gene transcriptional initiator in senescent T cells
    A N Vallejo
    Departments of Medicine and Immunology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    J Biol Chem 276:2565-70. 2001
  7. ncbi Central role of thrombospondin-1 in the activation and clonal expansion of inflammatory T cells
    A N Vallejo
    Division of Rheumatology, Department of Internal Medicine, Mayo Clinic Foundation, Rochester, MN 55905, USA
    J Immunol 164:2947-54. 2000
  8. ncbi Down-regulation of CD28 expression by TNF-alpha
    E Bryl
    Department of Medicine and Immunology, Mayo Clinic, Rochester, MN 55905, USA
    J Immunol 167:3231-8. 2001
  9. ncbi Molecular fingerprint of interferon-gamma signaling in unstable angina
    G Liuzzo
    Department of Medicine, Mayo Clinic and Foundation, Rochester, Minnesota, USA
    Circulation 103:1509-14. 2001
  10. ncbi CD28 extinction in human T cells: altered functions and the program of T-cell senescence
    Abbe N Vallejo
    Department of Pediatrics, University of Pittsburgh School of Medicine, Division of Rheumatology, Children s Hospital of Pittsburgh, PA 15213, USA
    Immunol Rev 205:158-69. 2005

Collaborators

  • C M Weyand
  • Jorg J Goronzy
  • M Schirmer
  • D R Holmes
  • G Liuzzo
  • Ewa Bryl
  • Tim Bongartz
  • C Turesson
  • A B Dietz
  • Kenneth J Warrington
  • Y Jiang
  • Joshua J Michel
  • Kristy Pilbeam
  • Bonnie H Lemster
  • Consuelo M López De Padilla
  • Bonnie Lemster
  • Keith Naylor
  • Sameem Abedin
  • Jing Xu
  • Dorothy E Lewis
  • Per Basse
  • Stephanie A Studenski
  • Nikola Vujanovic
  • Lisa Borghesi
  • David T Montag
  • John J Paat
  • Laurent Brossay
  • Anne B Newman
  • Rachel Gerstein
  • Stanimir Vuk-Pavlovic
  • Sarah R Atkins
  • Ann M Reed
  • Stephen A Smith
  • Eric L Matteson
  • Cristina Iclozan
  • Richard Vehe
  • Kelly T McNallan
  • Mary Chester Wasko
  • Guangjin Li
  • Jacek Witkowski
  • Won-Woo Lee
  • James Fulbright
  • Kerstin Koetz
  • Maria Merched-Sauvage

Detail Information

Publications23

  1. ncbi Modulation of CD28 expression: distinct regulatory pathways during activation and replicative senescence
    A N Vallejo
    Division of Rheumatology, Department of Medicine, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    J Immunol 162:6572-9. 1999
    ..In vivo expanded CD4+CD28null and CD8+CD28null T cells uniformly lack alpha- and beta-bound complexes, resembling the pattern seen in chronically activated cells and not of senescent cells...
  2. ncbi Biology of T lymphocytes
    Abbe N Vallejo
    Departments of Medicine and Immunology, Guggenheim 401, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Rheum Dis Clin North Am 30:135-57. 2004
    ..How we translate the cellular and molecular details of this regulation into innovation and development of therapies for disease management remains a fundamental, but exciting, challenge...
  3. ncbi Molecular basis for the loss of CD28 expression in senescent T cells
    Abbe N Vallejo
    Department of Medicine and Immunology, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Biol Chem 277:46940-9. 2002
    ..The present data also provide evidence for INR-regulated transcription that is independent of the known components of the basal transcription complex...
  4. ncbi T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection
    Abbe N Vallejo
    Division of Rheumatology, Department of Medicine, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    Trends Mol Med 10:119-24. 2004
    ..Indeed, studies on the molecular basis for the loss of CD28 are already providing information on methods to functionally rescue senescent T cells...
  5. ncbi Clonality and longevity of CD4+CD28null T cells are associated with defects in apoptotic pathways
    A N Vallejo
    Departments of Medicine and Immunology, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    J Immunol 165:6301-7. 2000
    ....
  6. ncbi Functional disruption of the CD28 gene transcriptional initiator in senescent T cells
    A N Vallejo
    Departments of Medicine and Immunology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    J Biol Chem 276:2565-70. 2001
    ..Rather, initiators can have a direct role in regulating the expression of specific genes. The gain or loss of initiator activity can be an important determinant of cell phenotypes...
  7. ncbi Central role of thrombospondin-1 in the activation and clonal expansion of inflammatory T cells
    A N Vallejo
    Division of Rheumatology, Department of Internal Medicine, Mayo Clinic Foundation, Rochester, MN 55905, USA
    J Immunol 164:2947-54. 2000
    ....
  8. ncbi Down-regulation of CD28 expression by TNF-alpha
    E Bryl
    Department of Medicine and Immunology, Mayo Clinic, Rochester, MN 55905, USA
    J Immunol 167:3231-8. 2001
    ..These results demonstrate that TNF-alpha directly influences CD28 gene transcription. We propose that the emergence of CD4(+)CD28(null) T cells in vivo is facilitated by increased production of TNF-alpha...
  9. ncbi Molecular fingerprint of interferon-gamma signaling in unstable angina
    G Liuzzo
    Department of Medicine, Mayo Clinic and Foundation, Rochester, Minnesota, USA
    Circulation 103:1509-14. 2001
    ..IFN-gamma may derive from stimulated T lymphocytes, which implicates specific immune responses in the pathogenesis of acute coronary syndromes...
  10. ncbi CD28 extinction in human T cells: altered functions and the program of T-cell senescence
    Abbe N Vallejo
    Department of Pediatrics, University of Pittsburgh School of Medicine, Division of Rheumatology, Children s Hospital of Pittsburgh, PA 15213, USA
    Immunol Rev 205:158-69. 2005
    ..Dissection of the machinery regulating CD28 expression is paving the way in elucidating the molecular events leading to immune senescence as well as providing clues into the functional rejuvenation of senescent T cells...
  11. ncbi Distinct transcriptional control mechanisms of killer immunoglobulin-like receptors in natural killer (NK) and in T cells
    Jing Xu
    Department of Medicine, Lowance Center for Human Immunology, Emory School of Medicine, Atlanta, Georgia 30322, USA
    J Biol Chem 280:24277-85. 2005
    ..We suggest that the regulated expression of KIRs in T cells profoundly influences peripheral tolerance and antigen-specific immune responses...
  12. ncbi Tumor necrosis factor-alpha and CD80 modulate CD28 expression through a similar mechanism of T-cell receptor-independent inhibition of transcription
    Dorothy E Lewis
    Department of Immunology, Baylor College of Medicine, Houston, Texas 77030, USA
    J Biol Chem 279:29130-8. 2004
    ..T cell lines with transient expression of CD28 are invaluable in the dissection of the biochemical processes involved in the transactivation of the CD28 INR, the silencing of which is a key event in the ontogenesis of senescent T cells...
  13. ncbi CD28 loss in senescent CD4+ T cells: reversal by interleukin-12 stimulation
    Kenneth J Warrington
    Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Blood 101:3543-9. 2003
    ..The re-expressed CD28 was functional and restored the ability of CD4(+)CD28(null) T cells to express CD25 and CD40 ligand. Our data suggest that IL-12 may, in part, functionally rescue senescent CD4(+) T cells...
  14. ncbi Synoviocyte-mediated expansion of inflammatory T cells in rheumatoid synovitis is dependent on CD47-thrombospondin 1 interaction
    Abbe N Vallejo
    Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    J Immunol 171:1732-40. 2003
    ..Because TSP1 is abundantly expressed in the rheumatoid synovium, CD47-TSP1 interaction is proposed to be a key component of an FLS/T cell regulatory circuit that perpetuates the inflammatory process in the rheumatoid joint...
  15. ncbi The ontogeny and fate of NK cells marked by permanent DNA rearrangements
    Kristy Pilbeam
    Department of Immunology, University of Pittsburgh School of Medicine, 200 Lothrop Street, Pittsburgh, PA 15261, USA
    J Immunol 180:1432-41. 2008
    ....
  16. ncbi Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis
    Consuelo M López De Padilla
    Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Arthritis Rheum 56:1658-68. 2007
    ..To examine whether dendritic cells (DCs) are constituents of muscle inflammation in juvenile dermatomyositis (DM)...
  17. ncbi Age-dependent alterations of the T cell repertoire and functional diversity of T cells of the aged
    Abbe N Vallejo
    Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
    Immunol Res 36:221-8. 2006
    ..Understanding the biology of NKR+ T cells will be pivotal to the development of strategies to enhance immunity in the elderly...
  18. ncbi Immune remodeling: lessons from repertoire alterations during chronological aging and in immune-mediated disease
    Abbe N Vallejo
    Departments of Pediatrics and Immunology, University of Pittsburgh School of Medicine, 3460 Fifth Avenue, Pittsburgh, PA 15213, USA
    Trends Mol Med 13:94-102. 2007
    ....
  19. ncbi CD56-expressing T cells that have features of senescence are expanded in rheumatoid arthritis
    Joshua J Michel
    Children s Hospital of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA
    Arthritis Rheum 56:43-57. 2007
    ..T cells deficient in CD28 expression have been implicated in the pathogenesis of rheumatoid arthritis (RA). Given that CD28-null T cells are functionally heterogeneous, we undertook this study to screen for novel receptors on these cells...
  20. ncbi Modulation of CD28 expression with anti-tumor necrosis factor alpha therapy in rheumatoid arthritis
    Ewa Bryl
    Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Arthritis Rheum 52:2996-3003. 2005
    ..CONCLUSION: Overproduction of TNFalpha in RA induces a global down-regulation of CD28 in CD4+ T cells and may cause reduced sensitivity to costimulatory signals in T cell responses...
  21. ncbi Diversity of NKR expression in aging T cells and in T cells of the aged: the new frontier into the exploration of protective immunity in the elderly
    Sameem Abedin
    Division of Rheumatology, Children's Hospital of Pittsburgh, PA 15213, USA
    Exp Gerontol 40:537-48. 2005
    ..We suggest that appreciation of the functional diversity of these unusual NK-like T cells is central to the creative development of new strategies to enhance protective immunity in the aged...
  22. ncbi The influence of age on T cell generation and TCR diversity
    Keith Naylor
    Department of Medicine, Mayo Clinic and Graduate School, Rochester, MN 55905, USA
    J Immunol 174:7446-52. 2005
    ..The collapse in CD4 T cell diversity during the seventh and eighth decades indicates substantial T cell loss and implies that therapeutic measures to improve vaccine responses will have to include strategies for T cell replenishment...
  23. ncbi Induction of CD56 and TCR-independent activation of T cells with aging
    Bonnie H Lemster
    Department of Pediatrics, University of Pittsburgh, PA 15213, USA
    J Immunol 180:1979-90. 2008
    ..CD56(+) T cells are unique effectors capable of mediating TCR-independent immune cascades that could be harnessed to enhance protective immunity in the elderly...